Use of Ctdna in Patients With Gastrointestinal Tract Tumors
Recruiting · NCT06202131 · Observational (researchers observe without assigning treatment) · Lead sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS
View the official record on ClinicalTrials.gov →What this trial is about
This study will evaluate the use of ctDNA in the clinical management of patients with tumors of the gastrointestinal tract.
Who can take part
Age range
18 Years to 85 Years
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)
Inclusion criteria
- Age \>18 years
- PS ECOG \<2;
- Histological diagnosis of gastrointestinal cancer: esophageal, gastric, intestinal, pancreatic, biliary tract neoplasms;
- Radiological evidence of resectable/locally advanced/metastatic disease on the date of signing the written informed consent;
- Adequate organ and function;
- Availability of tumor histological material.
Exclusion criteria
- No histological diagnosis of neoplasia of the gastrointestinal tract.
- No written informed consent.
Where it is running
2 locations listed.
- Policlinico Agostino Gemelli - Rome, Lazio, Italy
- Policlinico Agostino Gemelli - Rome, Lazio, Italy